Zurück zur Suche

Synthesis of hybrid drugs resulting from structure-based analysis of protein aggregation

Projektnummer

0052408

Zusammenfassung

In this propject, novel hybrid multifunctional compounds for preventing protein aggregation will be synthesized. Using Alzheimer diseases (AD) as the primary model, three existing A! binders which differ significantly, both in size and mode of action, will be used: monoclonal antibodies or recombinant fragements thereof (scFv) raised against various conformations of A!, D-peptides selected from phage display libraries, and aminopyrazoles specifically designed as beta-sheet ligands will be fused covalently to furnish hybrid compounds. By optimizing the length of flexible spacers, two di...

Projektinformationen

Status:

Beendet

Startdatum:

01.09.2007

Enddatum:

31.01.2012

Fördersumme:

706.000 €

Profilbereich:

Beendete Förderinitiativen

Förderinitiative:

Konformationelle Kontrolle biomolekularer Funktionen